You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NPM1m

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

Not yet recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • (no location specified)
Feb 17, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, NPM1 Mutation Trial in Bologna (Venetoclax+azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Bologna, Italy
    EMATOLOGIA- AOU Policlinico S.Orsola
Mar 1, 2022

Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Venetoclax plus Azacitidine
  • standard of care chemotherapy plus gemtuzumab ozogamicin
  • Essen, NRW, Germany
  • +17 more
Jun 6, 2023

Acute Lymphoblastic Leukemia, With Appropriate Mutations, Acute Myeloid Leukemia, With NPM1 Mutations Trial (ziftomenib)

Available
  • Acute Lymphoblastic Leukemia, With Appropriate Mutations
  • Acute Myeloid Leukemia, With NPM1 Mutations
  • (no location specified)
Feb 10, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Acute Myeloid Leukemia Trial in Austria, Germany (Gemtuzumab Ozogamicin (Mylotarg), standard chemo)

Completed
  • Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin (Mylotarg)
  • standard chemotherapy
  • Graz, Austria
  • +59 more
Sep 28, 2021

CBF and/or NPM1-mutated AML in First Molecular Relapse.

Recruiting
  • Acute Myeloid Leukemia
  • No intervention
  • Angers, France
    Angers University Hospital
Jun 14, 2021

NPMc+ AML Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

Recruiting
  • NPMc+ AML
  • Oral Arsenic Trioxide Formulation
  • Hong Kong, Hong Kong
    The University of Hong Kong
Dec 29, 2020

Healthy Women of Child Bearing Potential Trial (R21/Matrix-M1, Saline and R21/Matrix-M1, Sterile isotonic (0.9%) normal saline)

Not yet recruiting
  • Healthy Women of Child Bearing Potential
  • R21/Matrix-M1
  • +2 more
  • (no location specified)
Oct 10, 2023

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Immune-Mediated Inflammatory Disease Trial in Kópavogur (SK-M11/3A1 Digital health program)

Not yet recruiting
  • Immune-Mediated Inflammatory Disease
  • SK-M11/3A1 Digital health program
  • Kópavogur, Iceland
    Húðlæknastöðin dermatology clinic
Oct 26, 2023

Solid Tumors, Adult Trial in Dallas, Hangzhou (HF158K1 /Arm 2 mg/m², HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m²)

Not yet recruiting
  • Solid Tumors, Adult
  • HF158K1 /Arm 2 mg/m²
  • +5 more
  • Dallas, Texas
  • +2 more
May 6, 2023

Gynecological Malignancies Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Gynecological Malignancies
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 15, 2023

Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)

Not yet recruiting
  • Solid Tumor
  • M1-c6v1
  • Kashiwa-shi, Chiba, Japan
  • +2 more
Sep 19, 2023

HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

Recruiting
  • HIV Vaccine
  • HIV-1-infection
  • C62
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2022

Malaria Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Pvs230D1-EPA/Matrix-M)

Not yet recruiting
  • Malaria
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 28, 2023

Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)

Not yet recruiting
  • Chronic Pain
  • +2 more
  • Vitamin C
  • Placebo
  • Toronto, Ontario, Canada
  • +2 more
Nov 7, 2023

NSCLC Trial in Guangzhou (BL-M07D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 1, 2023

Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))

Suspended
  • Infection
  • Fecal Microbiota Transplantation (FMT)
  • Brampton, Ontario, Canada
  • +12 more
Nov 1, 2022

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023

NSCLC Trial in Shanghai (BL-M02D1)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023